High Note Wealth, LLC Biogen Inc. Transaction History

High Note Wealth, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$223.92 - $287.77 $1.52 Million - $1.95 Million	-6,766 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$282.99 - $369.05 $3,112 - $4,059	11 Added 0.16%	6,766 $1.91 Million
Q2 2021 Aug 04, 2021	SELL	$259.0 - $414.71 $17,871 - $28,614	-69 Reduced 1.01%	6,755 $2.34 Million
Q1 2021 May 04, 2021	BUY	$242.95 - $284.63 $57,093 - $66,888	235 Added 3.57%	6,824 $1.91 Million
Q4 2020 Feb 01, 2021	BUY	$236.26 - $355.63 $1.56 Million - $2.34 Million	6,589 New	6,589 $1.61 Million

1,038

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of High Note Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on High Note Wealth, LLC with notifications on news.